Central Trust Company’s Insulet PODD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$153 Hold
1
﹤0.01% 1559
2026
Q1
$210 Hold
1
﹤0.01% 1545
2025
Q4
$285 Hold
1
﹤0.01% 1488
2025
Q3
$309 Buy
+1
New +$313 ﹤0.01% 1384
2025
Q1
Sell
-7
Closed -$1.83K 1487
2024
Q4
$1.83K Buy
7
+6
+600% +$1.51K ﹤0.01% 1330
2024
Q3
$233 Buy
+1
New +$205 ﹤0.01% 1393
2024
Q1
Sell
-3
Closed -$651 1407
2023
Q4
$651 Buy
+3
New +$515 ﹤0.01% 1343
2023
Q3
Sell
-20
Closed -$5.77K 1380
2023
Q2
$5.77K Hold
20
﹤0.01% 1083
2023
Q1
$6.38K Hold
20
﹤0.01% 1090
2022
Q4
$5.89K Buy
+20
New +$5.52K ﹤0.01% 1070

Other funds holding PODD

Central Trust Company's PODD Position: Q2 2026 in Review

Central Trust Company held its Insulet (PODD) position steady in Q2 2026 at 1 share worth $153. The position accounts for ﹤0.01% of the portfolio, ranked #1559.

Central Trust Company first reported a position in PODD in Q4 2022 and has held it in 10 quarters since. The position peaked at $6.38K in Q1 2023. 229 funds tracked by Wall St. Rank hold PODD as of Q2 2026.

  • Central Trust Company held 1 share of Insulet worth $153 as of Q2 2026.
  • Central Trust Company left its Insulet share count unchanged in Q2 2026.
  • Insulet made up ﹤0.01% of Central Trust Company's portfolio in Q2 2026, its #1559 holding.
  • Central Trust Company first reported a position in Insulet in Q4 2022 and has held it in 10 quarters since.
  • Central Trust Company's Insulet position peaked at $6.38K in Q1 2023.
  • 229 funds tracked by Wall St. Rank held Insulet as of Q2 2026.

Based on Central Trust Company's 13F filing for Q2 2026, filed 31 Jul 2026.